Safety and Preliminary Efficacy of Intravenous Allogeneic Adipose-Derived Mesenchymal Stem Cells (GXIPC1) in Patients with Type 1 Diabetes Mellitus: A Phase 1, Single-Arm, Open-Label Clinical Trial
Fields of Study & Subjects
Pancreatic function and diabetes
Mesenchymal stem cell research
Diabetes and associated disorders
Publication details
- Journal / source
- Research Square
- Publication date
- 16 January 2026
- Document type
- Preprint